## Recent News

### [Carrick Therapeutics Announces Positive Results from Phase 2 Randomized Trial of Samuraciclib in Combination with Fulvestrant in Patients with Hormone Receptor Positive, HER2 Negative Advanced Breast Cancer](/content/news-media/press-releases/detail/27/carrick-therapeutics-announces-positive-results-from-phase/index.html)

Dec 10, 2025 1:30pm EST

### [Carrick Therapeutics Announces New Clinical Data Supporting Biomarker-driven Patient Selection for Samuraciclib (CDK7i) in Combination with SERDs in Hormone Receptor Positive Advanced Breast Cancer](/content/news-media/press-releases/detail/26/carrick-therapeutics-announces-new-clinical-data-supporting/index.html)

May 15, 2025 7:00am EDT